High Dose Rate Cobalt-60 After Loading Intracavitary Therapy of the Uterine Cervical Carcinoma in Srinagarind Hospital, Analysis of Residual Disease

CT Based 3-Dimensional Treatment Planning of Intracavitary Brachytherapy for Cancer of the Cervix : Comparison between Dose-Volume Histograms and ICRU Point Doses to the Rectum and Bladder

“…A retrospective review of 141 uterine cervical cancer patients (1b-IVb), treated with teletherapy combined with HDR cobalt-60 brachytherapy reported the mean onset time to develop radiation proctitis and radiation cystitis were 15 and 30 months respectively (Pesee et al, 2010) While many studies were looking at the relationship between dose and organs at risk toxicities, Lin Yang and Yin LV (2012) analysed the possible risk factors associated with the development of radiation proctitis or radiation cystitis in 1518 cervical cancer patients following radiation therapy. The prevalence of Grade 1 and 2 radiation proctitis and radiation cystitis was lower than Grade 3 and was significantly higher in patients with late stage tumour (IIIb).…”

Possible Risk Factors Associated with Radiation Proctitis or Radiation Cystitis in Patients with Cervical Carcinoma after Radiotherapy

“…A similar follow-up study revealed that among 240 cases of Stage I to Stage III cervical carcinoma, 13.3% and 8.8% patients had severe radiation proctitis and radiation cystitis, respectively, following ICBT combined with EBRT (Yu et al, 2004). A retrospective study patients diagnosed with Stages IB to IVB uterine cervical cancer showed that combined teletherapy along with high dose rate Cobalt -60 brachytherapy (850 cGy/ fraction weekly to Point A for two fractions) led to a slightly higher incidence of Grade 2 radiation proctitis (Pesee et al, 2010). In this present study, we retrospectively analyzed 1518 women who received radiotherapy in our hospital for the treatment of cervical carcinoma.…”

Palliative Treatment of Advanced Cervical Cancer with Radiotherapy and Thai Herbal Medicine as Supportive Remedy - Analysis of Survival

“…The factors influencing overall survival are tumor size, staging, hemoglobin level, interval between external-intracavitary radiation and radiotherapy (Pomros et al, 2007). The overall 5 year survival rate of stage IIIB cervical cancer by using CCPR was 52% when compared with 34-54.8% of historic controls (Arai et al, 1992;Lorvidhaya et al, 2000;Rose et al, 2007;Wong et al, 2003;Pesee et al, 2010). In addition, the overall 3 year survival rate of 3D conformal radiotherapy with or without chemotherapy plus image (MRI) guided adaptive intracavitary brachytherapy was 45% for stage IIIB cervical cancer (Potter et al, 2011).…”